nodes	percent_of_prediction	percent_of_DWPC	metapath
Alfentanil—ORM1—Erlotinib—pancreatic cancer	0.102	0.115	CbGbCtD
Alfentanil—CYP3A7—Tamoxifen—pancreatic cancer	0.0543	0.0612	CbGbCtD
Alfentanil—CYP3A7-CYP3A51P—Tamoxifen—pancreatic cancer	0.0543	0.0612	CbGbCtD
Alfentanil—ALB—Erlotinib—pancreatic cancer	0.0431	0.0485	CbGbCtD
Alfentanil—CYP3A7—Irinotecan—pancreatic cancer	0.0417	0.047	CbGbCtD
Alfentanil—CYP3A7-CYP3A51P—Irinotecan—pancreatic cancer	0.0417	0.047	CbGbCtD
Alfentanil—CYP3A5—Tamoxifen—pancreatic cancer	0.0407	0.0459	CbGbCtD
Alfentanil—ALB—Irinotecan—pancreatic cancer	0.0389	0.0438	CbGbCtD
Alfentanil—ALB—Fluorouracil—pancreatic cancer	0.0373	0.0421	CbGbCtD
Alfentanil—CYP3A5—Erlotinib—pancreatic cancer	0.0346	0.039	CbGbCtD
Alfentanil—CYP3A5—Irinotecan—pancreatic cancer	0.0313	0.0352	CbGbCtD
Alfentanil—CYP3A7-CYP3A51P—Docetaxel—pancreatic cancer	0.0305	0.0344	CbGbCtD
Alfentanil—CYP3A7—Docetaxel—pancreatic cancer	0.0305	0.0344	CbGbCtD
Alfentanil—CYP3A7-CYP3A51P—Sunitinib—pancreatic cancer	0.0304	0.0343	CbGbCtD
Alfentanil—CYP3A7—Sunitinib—pancreatic cancer	0.0304	0.0343	CbGbCtD
Alfentanil—ABCB1—Tamoxifen—pancreatic cancer	0.0265	0.0299	CbGbCtD
Alfentanil—CYP3A5—Docetaxel—pancreatic cancer	0.0229	0.0258	CbGbCtD
Alfentanil—ABCB1—Gemcitabine—pancreatic cancer	0.0228	0.0257	CbGbCtD
Alfentanil—CYP3A5—Sunitinib—pancreatic cancer	0.0228	0.0257	CbGbCtD
Alfentanil—ABCB1—Erlotinib—pancreatic cancer	0.0225	0.0254	CbGbCtD
Alfentanil—ABCB1—Irinotecan—pancreatic cancer	0.0204	0.0229	CbGbCtD
Alfentanil—CYP3A4—Tamoxifen—pancreatic cancer	0.0159	0.0179	CbGbCtD
Alfentanil—ABCB1—Docetaxel—pancreatic cancer	0.0149	0.0168	CbGbCtD
Alfentanil—ABCB1—Sunitinib—pancreatic cancer	0.0148	0.0167	CbGbCtD
Alfentanil—CYP3A4—Erlotinib—pancreatic cancer	0.0135	0.0152	CbGbCtD
Alfentanil—CYP3A4—Irinotecan—pancreatic cancer	0.0122	0.0137	CbGbCtD
Alfentanil—ABCB1—Doxorubicin—pancreatic cancer	0.0111	0.0125	CbGbCtD
Alfentanil—CYP3A4—Docetaxel—pancreatic cancer	0.00894	0.0101	CbGbCtD
Alfentanil—CYP3A4—Sunitinib—pancreatic cancer	0.0089	0.01	CbGbCtD
Alfentanil—CYP3A4—Doxorubicin—pancreatic cancer	0.00666	0.00751	CbGbCtD
Alfentanil—ORM1—bile—pancreatic cancer	0.00103	0.52	CbGeAlD
Alfentanil—Cardiac disorder—Gemcitabine—pancreatic cancer	0.000472	0.00427	CcSEcCtD
Alfentanil—Immune system disorder—Irinotecan—pancreatic cancer	0.000472	0.00427	CcSEcCtD
Alfentanil—Mediastinal disorder—Irinotecan—pancreatic cancer	0.000471	0.00426	CcSEcCtD
Alfentanil—Chills—Irinotecan—pancreatic cancer	0.000468	0.00424	CcSEcCtD
Alfentanil—Unspecified disorder of skin and subcutaneous tissue—Sunitinib—pancreatic cancer	0.000466	0.00422	CcSEcCtD
Alfentanil—Arrhythmia—Irinotecan—pancreatic cancer	0.000466	0.00422	CcSEcCtD
Alfentanil—Angiopathy—Gemcitabine—pancreatic cancer	0.000461	0.00417	CcSEcCtD
Alfentanil—Immune system disorder—Gemcitabine—pancreatic cancer	0.000459	0.00415	CcSEcCtD
Alfentanil—Mediastinal disorder—Gemcitabine—pancreatic cancer	0.000458	0.00415	CcSEcCtD
Alfentanil—Chills—Gemcitabine—pancreatic cancer	0.000456	0.00413	CcSEcCtD
Alfentanil—Arrhythmia—Gemcitabine—pancreatic cancer	0.000454	0.00411	CcSEcCtD
Alfentanil—Gastrointestinal disorder—Tamoxifen—pancreatic cancer	0.000454	0.00411	CcSEcCtD
Alfentanil—Fatigue—Tamoxifen—pancreatic cancer	0.000453	0.0041	CcSEcCtD
Alfentanil—Pain—Tamoxifen—pancreatic cancer	0.00045	0.00407	CcSEcCtD
Alfentanil—Gastrointestinal disorder—Erlotinib—pancreatic cancer	0.000449	0.00406	CcSEcCtD
Alfentanil—Hiccups—Doxorubicin—pancreatic cancer	0.000449	0.00406	CcSEcCtD
Alfentanil—Fatigue—Erlotinib—pancreatic cancer	0.000448	0.00406	CcSEcCtD
Alfentanil—Arrhythmia—Fluorouracil—pancreatic cancer	0.000447	0.00404	CcSEcCtD
Alfentanil—Pain—Erlotinib—pancreatic cancer	0.000445	0.00402	CcSEcCtD
Alfentanil—Bronchospasm—Docetaxel—pancreatic cancer	0.000444	0.00401	CcSEcCtD
Alfentanil—Erythema—Gemcitabine—pancreatic cancer	0.000443	0.004	CcSEcCtD
Alfentanil—Nervous system disorder—Sunitinib—pancreatic cancer	0.000442	0.00399	CcSEcCtD
Alfentanil—Skin disorder—Sunitinib—pancreatic cancer	0.000437	0.00396	CcSEcCtD
Alfentanil—Erythema—Fluorouracil—pancreatic cancer	0.000435	0.00394	CcSEcCtD
Alfentanil—Urticaria—Tamoxifen—pancreatic cancer	0.000418	0.00378	CcSEcCtD
Alfentanil—Body temperature increased—Erlotinib—pancreatic cancer	0.000411	0.00372	CcSEcCtD
Alfentanil—Vision blurred—Fluorouracil—pancreatic cancer	0.00041	0.00371	CcSEcCtD
Alfentanil—Loss of consciousness—Irinotecan—pancreatic cancer	0.000399	0.00361	CcSEcCtD
Alfentanil—Cough—Irinotecan—pancreatic cancer	0.000397	0.00359	CcSEcCtD
Alfentanil—Hypertension—Irinotecan—pancreatic cancer	0.000392	0.00355	CcSEcCtD
Alfentanil—Gastrointestinal disorder—Sunitinib—pancreatic cancer	0.000389	0.00352	CcSEcCtD
Alfentanil—Fatigue—Sunitinib—pancreatic cancer	0.000388	0.00351	CcSEcCtD
Alfentanil—Hypersensitivity—Tamoxifen—pancreatic cancer	0.000387	0.0035	CcSEcCtD
Alfentanil—Cough—Gemcitabine—pancreatic cancer	0.000386	0.00349	CcSEcCtD
Alfentanil—Pain—Sunitinib—pancreatic cancer	0.000385	0.00348	CcSEcCtD
Alfentanil—Hypertension—Gemcitabine—pancreatic cancer	0.000382	0.00346	CcSEcCtD
Alfentanil—Epistaxis—Docetaxel—pancreatic cancer	0.000379	0.00343	CcSEcCtD
Alfentanil—Asthenia—Tamoxifen—pancreatic cancer	0.000377	0.00341	CcSEcCtD
Alfentanil—Convulsion—Fluorouracil—pancreatic cancer	0.000377	0.00341	CcSEcCtD
Alfentanil—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—pancreatic cancer	0.000374	0.00339	CcSEcCtD
Alfentanil—Confusional state—Irinotecan—pancreatic cancer	0.000374	0.00338	CcSEcCtD
Alfentanil—Asthenia—Erlotinib—pancreatic cancer	0.000373	0.00338	CcSEcCtD
Alfentanil—Pruritus—Tamoxifen—pancreatic cancer	0.000372	0.00336	CcSEcCtD
Alfentanil—Anaphylactic shock—Irinotecan—pancreatic cancer	0.000371	0.00336	CcSEcCtD
Alfentanil—Pruritus—Erlotinib—pancreatic cancer	0.000368	0.00333	CcSEcCtD
Alfentanil—Nervous system disorder—Irinotecan—pancreatic cancer	0.000364	0.00329	CcSEcCtD
Alfentanil—Anaphylactoid reaction—Epirubicin—pancreatic cancer	0.000364	0.00329	CcSEcCtD
Alfentanil—Anaphylactic shock—Gemcitabine—pancreatic cancer	0.000361	0.00327	CcSEcCtD
Alfentanil—Hyperhidrosis—Irinotecan—pancreatic cancer	0.000359	0.00324	CcSEcCtD
Alfentanil—Confusional state—Fluorouracil—pancreatic cancer	0.000358	0.00324	CcSEcCtD
Alfentanil—Body temperature increased—Sunitinib—pancreatic cancer	0.000356	0.00322	CcSEcCtD
Alfentanil—Anaphylactic shock—Fluorouracil—pancreatic cancer	0.000355	0.00321	CcSEcCtD
Alfentanil—Connective tissue disorder—Docetaxel—pancreatic cancer	0.000355	0.00321	CcSEcCtD
Alfentanil—Nervous system disorder—Gemcitabine—pancreatic cancer	0.000354	0.0032	CcSEcCtD
Alfentanil—Skin disorder—Gemcitabine—pancreatic cancer	0.000351	0.00317	CcSEcCtD
Alfentanil—Hyperhidrosis—Gemcitabine—pancreatic cancer	0.000349	0.00316	CcSEcCtD
Alfentanil—Nervous system disorder—Fluorouracil—pancreatic cancer	0.000348	0.00315	CcSEcCtD
Alfentanil—Visual impairment—Docetaxel—pancreatic cancer	0.000348	0.00315	CcSEcCtD
Alfentanil—Dizziness—Tamoxifen—pancreatic cancer	0.000348	0.00314	CcSEcCtD
Alfentanil—Tachycardia—Fluorouracil—pancreatic cancer	0.000347	0.00314	CcSEcCtD
Alfentanil—Hypotension—Irinotecan—pancreatic cancer	0.000347	0.00314	CcSEcCtD
Alfentanil—Dizziness—Erlotinib—pancreatic cancer	0.000344	0.00311	CcSEcCtD
Alfentanil—Hypotension—Gemcitabine—pancreatic cancer	0.000338	0.00305	CcSEcCtD
Alfentanil—Eye disorder—Docetaxel—pancreatic cancer	0.000337	0.00305	CcSEcCtD
Alfentanil—Anaphylactoid reaction—Doxorubicin—pancreatic cancer	0.000336	0.00304	CcSEcCtD
Alfentanil—Cardiac disorder—Docetaxel—pancreatic cancer	0.000335	0.00303	CcSEcCtD
Alfentanil—Cardiac arrest—Epirubicin—pancreatic cancer	0.000335	0.00303	CcSEcCtD
Alfentanil—Vomiting—Tamoxifen—pancreatic cancer	0.000334	0.00302	CcSEcCtD
Alfentanil—Hypotension—Fluorouracil—pancreatic cancer	0.000332	0.003	CcSEcCtD
Alfentanil—Hypersensitivity—Sunitinib—pancreatic cancer	0.000332	0.003	CcSEcCtD
Alfentanil—Rash—Tamoxifen—pancreatic cancer	0.000331	0.003	CcSEcCtD
Alfentanil—Dermatitis—Tamoxifen—pancreatic cancer	0.000331	0.003	CcSEcCtD
Alfentanil—Vomiting—Erlotinib—pancreatic cancer	0.000331	0.00299	CcSEcCtD
Alfentanil—Somnolence—Irinotecan—pancreatic cancer	0.00033	0.00298	CcSEcCtD
Alfentanil—Headache—Tamoxifen—pancreatic cancer	0.000329	0.00298	CcSEcCtD
Alfentanil—Rash—Erlotinib—pancreatic cancer	0.000328	0.00297	CcSEcCtD
Alfentanil—Dermatitis—Erlotinib—pancreatic cancer	0.000328	0.00296	CcSEcCtD
Alfentanil—Angiopathy—Docetaxel—pancreatic cancer	0.000327	0.00296	CcSEcCtD
Alfentanil—Immune system disorder—Docetaxel—pancreatic cancer	0.000326	0.00295	CcSEcCtD
Alfentanil—Headache—Erlotinib—pancreatic cancer	0.000326	0.00295	CcSEcCtD
Alfentanil—Mediastinal disorder—Docetaxel—pancreatic cancer	0.000325	0.00294	CcSEcCtD
Alfentanil—Chills—Docetaxel—pancreatic cancer	0.000324	0.00293	CcSEcCtD
Alfentanil—Asthenia—Sunitinib—pancreatic cancer	0.000323	0.00292	CcSEcCtD
Alfentanil—Arrhythmia—Docetaxel—pancreatic cancer	0.000322	0.00292	CcSEcCtD
Alfentanil—Somnolence—Gemcitabine—pancreatic cancer	0.000321	0.00291	CcSEcCtD
Alfentanil—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.00032	0.0029	CcSEcCtD
Alfentanil—Fatigue—Irinotecan—pancreatic cancer	0.00032	0.00289	CcSEcCtD
Alfentanil—Pruritus—Sunitinib—pancreatic cancer	0.000319	0.00288	CcSEcCtD
Alfentanil—Pain—Irinotecan—pancreatic cancer	0.000317	0.00287	CcSEcCtD
Alfentanil—Mental disorder—Docetaxel—pancreatic cancer	0.000316	0.00286	CcSEcCtD
Alfentanil—Somnolence—Fluorouracil—pancreatic cancer	0.000316	0.00286	CcSEcCtD
Alfentanil—Erythema—Docetaxel—pancreatic cancer	0.000314	0.00284	CcSEcCtD
Alfentanil—Nausea—Tamoxifen—pancreatic cancer	0.000312	0.00282	CcSEcCtD
Alfentanil—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.000312	0.00282	CcSEcCtD
Alfentanil—Fatigue—Gemcitabine—pancreatic cancer	0.000312	0.00282	CcSEcCtD
Alfentanil—Cardiac arrest—Doxorubicin—pancreatic cancer	0.00031	0.0028	CcSEcCtD
Alfentanil—Pain—Gemcitabine—pancreatic cancer	0.000309	0.00279	CcSEcCtD
Alfentanil—Nausea—Erlotinib—pancreatic cancer	0.000309	0.00279	CcSEcCtD
Alfentanil—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.000307	0.00277	CcSEcCtD
Alfentanil—Feeling abnormal—Irinotecan—pancreatic cancer	0.000306	0.00276	CcSEcCtD
Alfentanil—Pain—Fluorouracil—pancreatic cancer	0.000304	0.00275	CcSEcCtD
Alfentanil—Dizziness—Sunitinib—pancreatic cancer	0.000298	0.00269	CcSEcCtD
Alfentanil—Feeling abnormal—Gemcitabine—pancreatic cancer	0.000298	0.00269	CcSEcCtD
Alfentanil—Body temperature increased—Irinotecan—pancreatic cancer	0.000293	0.00265	CcSEcCtD
Alfentanil—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000293	0.00265	CcSEcCtD
Alfentanil—Vomiting—Sunitinib—pancreatic cancer	0.000286	0.00259	CcSEcCtD
Alfentanil—ORM1—gall bladder—pancreatic cancer	0.000286	0.144	CbGeAlD
Alfentanil—Body temperature increased—Gemcitabine—pancreatic cancer	0.000286	0.00258	CcSEcCtD
Alfentanil—Rash—Sunitinib—pancreatic cancer	0.000284	0.00257	CcSEcCtD
Alfentanil—Dermatitis—Sunitinib—pancreatic cancer	0.000284	0.00257	CcSEcCtD
Alfentanil—Urticaria—Fluorouracil—pancreatic cancer	0.000282	0.00255	CcSEcCtD
Alfentanil—Headache—Sunitinib—pancreatic cancer	0.000282	0.00255	CcSEcCtD
Alfentanil—Body temperature increased—Fluorouracil—pancreatic cancer	0.000281	0.00254	CcSEcCtD
Alfentanil—Loss of consciousness—Docetaxel—pancreatic cancer	0.000276	0.0025	CcSEcCtD
Alfentanil—Cough—Docetaxel—pancreatic cancer	0.000274	0.00248	CcSEcCtD
Alfentanil—Hypersensitivity—Irinotecan—pancreatic cancer	0.000273	0.00247	CcSEcCtD
Alfentanil—Convulsion—Docetaxel—pancreatic cancer	0.000272	0.00246	CcSEcCtD
Alfentanil—Hypertension—Docetaxel—pancreatic cancer	0.000271	0.00245	CcSEcCtD
Alfentanil—Drowsiness—Epirubicin—pancreatic cancer	0.000271	0.00245	CcSEcCtD
Alfentanil—Nausea—Sunitinib—pancreatic cancer	0.000267	0.00242	CcSEcCtD
Alfentanil—Asthenia—Irinotecan—pancreatic cancer	0.000266	0.00241	CcSEcCtD
Alfentanil—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000266	0.0024	CcSEcCtD
Alfentanil—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000262	0.00237	CcSEcCtD
Alfentanil—Asthenia—Gemcitabine—pancreatic cancer	0.000259	0.00234	CcSEcCtD
Alfentanil—Confusional state—Docetaxel—pancreatic cancer	0.000259	0.00234	CcSEcCtD
Alfentanil—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000256	0.00232	CcSEcCtD
Alfentanil—Epistaxis—Epirubicin—pancreatic cancer	0.000256	0.00231	CcSEcCtD
Alfentanil—Pruritus—Gemcitabine—pancreatic cancer	0.000256	0.00231	CcSEcCtD
Alfentanil—Nervous system disorder—Docetaxel—pancreatic cancer	0.000251	0.00227	CcSEcCtD
Alfentanil—Pruritus—Fluorouracil—pancreatic cancer	0.000251	0.00227	CcSEcCtD
Alfentanil—Drowsiness—Doxorubicin—pancreatic cancer	0.000251	0.00227	CcSEcCtD
Alfentanil—ALB—gall bladder—pancreatic cancer	0.000251	0.127	CbGeAlD
Alfentanil—Tachycardia—Docetaxel—pancreatic cancer	0.00025	0.00226	CcSEcCtD
Alfentanil—Skin disorder—Docetaxel—pancreatic cancer	0.000249	0.00225	CcSEcCtD
Alfentanil—Bradycardia—Epirubicin—pancreatic cancer	0.000248	0.00224	CcSEcCtD
Alfentanil—Dizziness—Irinotecan—pancreatic cancer	0.000245	0.00222	CcSEcCtD
Alfentanil—Hypotension—Docetaxel—pancreatic cancer	0.00024	0.00217	CcSEcCtD
Alfentanil—Connective tissue disorder—Epirubicin—pancreatic cancer	0.000239	0.00216	CcSEcCtD
Alfentanil—Epistaxis—Doxorubicin—pancreatic cancer	0.000237	0.00214	CcSEcCtD
Alfentanil—Vomiting—Irinotecan—pancreatic cancer	0.000236	0.00213	CcSEcCtD
Alfentanil—Dizziness—Fluorouracil—pancreatic cancer	0.000235	0.00212	CcSEcCtD
Alfentanil—Visual impairment—Epirubicin—pancreatic cancer	0.000235	0.00212	CcSEcCtD
Alfentanil—Rash—Irinotecan—pancreatic cancer	0.000234	0.00212	CcSEcCtD
Alfentanil—Dermatitis—Irinotecan—pancreatic cancer	0.000234	0.00211	CcSEcCtD
Alfentanil—Headache—Irinotecan—pancreatic cancer	0.000232	0.0021	CcSEcCtD
Alfentanil—Vomiting—Gemcitabine—pancreatic cancer	0.00023	0.00208	CcSEcCtD
Alfentanil—Bradycardia—Doxorubicin—pancreatic cancer	0.000229	0.00207	CcSEcCtD
Alfentanil—Somnolence—Docetaxel—pancreatic cancer	0.000228	0.00206	CcSEcCtD
Alfentanil—Rash—Gemcitabine—pancreatic cancer	0.000228	0.00206	CcSEcCtD
Alfentanil—Dermatitis—Gemcitabine—pancreatic cancer	0.000228	0.00206	CcSEcCtD
Alfentanil—Eye disorder—Epirubicin—pancreatic cancer	0.000227	0.00206	CcSEcCtD
Alfentanil—Headache—Gemcitabine—pancreatic cancer	0.000226	0.00205	CcSEcCtD
Alfentanil—Cardiac disorder—Epirubicin—pancreatic cancer	0.000226	0.00204	CcSEcCtD
Alfentanil—Vomiting—Fluorouracil—pancreatic cancer	0.000226	0.00204	CcSEcCtD
Alfentanil—Rash—Fluorouracil—pancreatic cancer	0.000224	0.00203	CcSEcCtD
Alfentanil—Dermatitis—Fluorouracil—pancreatic cancer	0.000224	0.00202	CcSEcCtD
Alfentanil—Headache—Fluorouracil—pancreatic cancer	0.000223	0.00201	CcSEcCtD
Alfentanil—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000221	0.002	CcSEcCtD
Alfentanil—Connective tissue disorder—Doxorubicin—pancreatic cancer	0.000221	0.002	CcSEcCtD
Alfentanil—Fatigue—Docetaxel—pancreatic cancer	0.000221	0.002	CcSEcCtD
Alfentanil—Angiopathy—Epirubicin—pancreatic cancer	0.000221	0.002	CcSEcCtD
Alfentanil—Nausea—Irinotecan—pancreatic cancer	0.00022	0.00199	CcSEcCtD
Alfentanil—Immune system disorder—Epirubicin—pancreatic cancer	0.00022	0.00199	CcSEcCtD
Alfentanil—Mediastinal disorder—Epirubicin—pancreatic cancer	0.000219	0.00198	CcSEcCtD
Alfentanil—Pain—Docetaxel—pancreatic cancer	0.000219	0.00198	CcSEcCtD
Alfentanil—Chills—Epirubicin—pancreatic cancer	0.000218	0.00198	CcSEcCtD
Alfentanil—Arrhythmia—Epirubicin—pancreatic cancer	0.000217	0.00197	CcSEcCtD
Alfentanil—Visual impairment—Doxorubicin—pancreatic cancer	0.000217	0.00196	CcSEcCtD
Alfentanil—Nausea—Gemcitabine—pancreatic cancer	0.000215	0.00194	CcSEcCtD
Alfentanil—Mental disorder—Epirubicin—pancreatic cancer	0.000213	0.00193	CcSEcCtD
Alfentanil—Erythema—Epirubicin—pancreatic cancer	0.000212	0.00192	CcSEcCtD
Alfentanil—Feeling abnormal—Docetaxel—pancreatic cancer	0.000211	0.00191	CcSEcCtD
Alfentanil—Nausea—Fluorouracil—pancreatic cancer	0.000211	0.00191	CcSEcCtD
Alfentanil—Eye disorder—Doxorubicin—pancreatic cancer	0.00021	0.0019	CcSEcCtD
Alfentanil—Cardiac disorder—Doxorubicin—pancreatic cancer	0.000209	0.00189	CcSEcCtD
Alfentanil—Angiopathy—Doxorubicin—pancreatic cancer	0.000204	0.00185	CcSEcCtD
Alfentanil—Immune system disorder—Doxorubicin—pancreatic cancer	0.000203	0.00184	CcSEcCtD
Alfentanil—Mediastinal disorder—Doxorubicin—pancreatic cancer	0.000203	0.00184	CcSEcCtD
Alfentanil—Body temperature increased—Docetaxel—pancreatic cancer	0.000203	0.00183	CcSEcCtD
Alfentanil—Chills—Doxorubicin—pancreatic cancer	0.000202	0.00183	CcSEcCtD
Alfentanil—Arrhythmia—Doxorubicin—pancreatic cancer	0.000201	0.00182	CcSEcCtD
Alfentanil—Vision blurred—Epirubicin—pancreatic cancer	0.0002	0.00181	CcSEcCtD
Alfentanil—Mental disorder—Doxorubicin—pancreatic cancer	0.000197	0.00178	CcSEcCtD
Alfentanil—Erythema—Doxorubicin—pancreatic cancer	0.000196	0.00177	CcSEcCtD
Alfentanil—Agitation—Epirubicin—pancreatic cancer	0.000195	0.00176	CcSEcCtD
Alfentanil—Hypersensitivity—Docetaxel—pancreatic cancer	0.000189	0.00171	CcSEcCtD
Alfentanil—Loss of consciousness—Epirubicin—pancreatic cancer	0.000186	0.00168	CcSEcCtD
Alfentanil—Cough—Epirubicin—pancreatic cancer	0.000185	0.00167	CcSEcCtD
Alfentanil—Vision blurred—Doxorubicin—pancreatic cancer	0.000185	0.00167	CcSEcCtD
Alfentanil—Asthenia—Docetaxel—pancreatic cancer	0.000184	0.00166	CcSEcCtD
Alfentanil—Convulsion—Epirubicin—pancreatic cancer	0.000184	0.00166	CcSEcCtD
Alfentanil—Hypertension—Epirubicin—pancreatic cancer	0.000183	0.00165	CcSEcCtD
Alfentanil—Pruritus—Docetaxel—pancreatic cancer	0.000181	0.00164	CcSEcCtD
Alfentanil—Agitation—Doxorubicin—pancreatic cancer	0.00018	0.00163	CcSEcCtD
Alfentanil—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000179	0.00162	CcSEcCtD
Alfentanil—Confusional state—Epirubicin—pancreatic cancer	0.000174	0.00158	CcSEcCtD
Alfentanil—Anaphylactic shock—Epirubicin—pancreatic cancer	0.000173	0.00156	CcSEcCtD
Alfentanil—Loss of consciousness—Doxorubicin—pancreatic cancer	0.000172	0.00156	CcSEcCtD
Alfentanil—Cough—Doxorubicin—pancreatic cancer	0.000171	0.00155	CcSEcCtD
Alfentanil—Convulsion—Doxorubicin—pancreatic cancer	0.00017	0.00154	CcSEcCtD
Alfentanil—Nervous system disorder—Epirubicin—pancreatic cancer	0.00017	0.00153	CcSEcCtD
Alfentanil—Dizziness—Docetaxel—pancreatic cancer	0.00017	0.00153	CcSEcCtD
Alfentanil—Hypertension—Doxorubicin—pancreatic cancer	0.000169	0.00153	CcSEcCtD
Alfentanil—Tachycardia—Epirubicin—pancreatic cancer	0.000169	0.00153	CcSEcCtD
Alfentanil—Skin disorder—Epirubicin—pancreatic cancer	0.000168	0.00152	CcSEcCtD
Alfentanil—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000167	0.00151	CcSEcCtD
Alfentanil—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000166	0.0015	CcSEcCtD
Alfentanil—Vomiting—Docetaxel—pancreatic cancer	0.000163	0.00147	CcSEcCtD
Alfentanil—Rash—Docetaxel—pancreatic cancer	0.000162	0.00146	CcSEcCtD
Alfentanil—Hypotension—Epirubicin—pancreatic cancer	0.000162	0.00146	CcSEcCtD
Alfentanil—Dermatitis—Docetaxel—pancreatic cancer	0.000162	0.00146	CcSEcCtD
Alfentanil—Confusional state—Doxorubicin—pancreatic cancer	0.000161	0.00146	CcSEcCtD
Alfentanil—Headache—Docetaxel—pancreatic cancer	0.000161	0.00145	CcSEcCtD
Alfentanil—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.00016	0.00145	CcSEcCtD
Alfentanil—Nervous system disorder—Doxorubicin—pancreatic cancer	0.000157	0.00142	CcSEcCtD
Alfentanil—Tachycardia—Doxorubicin—pancreatic cancer	0.000156	0.00141	CcSEcCtD
Alfentanil—Skin disorder—Doxorubicin—pancreatic cancer	0.000155	0.00141	CcSEcCtD
Alfentanil—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000155	0.0014	CcSEcCtD
Alfentanil—Somnolence—Epirubicin—pancreatic cancer	0.000154	0.00139	CcSEcCtD
Alfentanil—Nausea—Docetaxel—pancreatic cancer	0.000152	0.00138	CcSEcCtD
Alfentanil—Hypotension—Doxorubicin—pancreatic cancer	0.00015	0.00135	CcSEcCtD
Alfentanil—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000149	0.00135	CcSEcCtD
Alfentanil—Fatigue—Epirubicin—pancreatic cancer	0.000149	0.00135	CcSEcCtD
Alfentanil—Pain—Epirubicin—pancreatic cancer	0.000148	0.00134	CcSEcCtD
Alfentanil—Feeling abnormal—Epirubicin—pancreatic cancer	0.000143	0.00129	CcSEcCtD
Alfentanil—Somnolence—Doxorubicin—pancreatic cancer	0.000142	0.00129	CcSEcCtD
Alfentanil—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000138	0.00125	CcSEcCtD
Alfentanil—Fatigue—Doxorubicin—pancreatic cancer	0.000138	0.00125	CcSEcCtD
Alfentanil—Urticaria—Epirubicin—pancreatic cancer	0.000137	0.00124	CcSEcCtD
Alfentanil—Pain—Doxorubicin—pancreatic cancer	0.000137	0.00124	CcSEcCtD
Alfentanil—Body temperature increased—Epirubicin—pancreatic cancer	0.000137	0.00124	CcSEcCtD
Alfentanil—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000132	0.00119	CcSEcCtD
Alfentanil—Hypersensitivity—Epirubicin—pancreatic cancer	0.000127	0.00115	CcSEcCtD
Alfentanil—Urticaria—Doxorubicin—pancreatic cancer	0.000127	0.00115	CcSEcCtD
Alfentanil—Body temperature increased—Doxorubicin—pancreatic cancer	0.000126	0.00114	CcSEcCtD
Alfentanil—Asthenia—Epirubicin—pancreatic cancer	0.000124	0.00112	CcSEcCtD
Alfentanil—Pruritus—Epirubicin—pancreatic cancer	0.000122	0.00111	CcSEcCtD
Alfentanil—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000118	0.00107	CcSEcCtD
Alfentanil—Asthenia—Doxorubicin—pancreatic cancer	0.000115	0.00104	CcSEcCtD
Alfentanil—Dizziness—Epirubicin—pancreatic cancer	0.000114	0.00103	CcSEcCtD
Alfentanil—Pruritus—Doxorubicin—pancreatic cancer	0.000113	0.00102	CcSEcCtD
Alfentanil—Vomiting—Epirubicin—pancreatic cancer	0.00011	0.000995	CcSEcCtD
Alfentanil—Rash—Epirubicin—pancreatic cancer	0.000109	0.000986	CcSEcCtD
Alfentanil—Dermatitis—Epirubicin—pancreatic cancer	0.000109	0.000985	CcSEcCtD
Alfentanil—Headache—Epirubicin—pancreatic cancer	0.000108	0.00098	CcSEcCtD
Alfentanil—Dizziness—Doxorubicin—pancreatic cancer	0.000106	0.000957	CcSEcCtD
Alfentanil—CYP3A5—islet of Langerhans—pancreatic cancer	0.000104	0.0526	CbGeAlD
Alfentanil—Nausea—Epirubicin—pancreatic cancer	0.000103	0.000929	CcSEcCtD
Alfentanil—Vomiting—Doxorubicin—pancreatic cancer	0.000102	0.00092	CcSEcCtD
Alfentanil—Rash—Doxorubicin—pancreatic cancer	0.000101	0.000913	CcSEcCtD
Alfentanil—Dermatitis—Doxorubicin—pancreatic cancer	0.000101	0.000912	CcSEcCtD
Alfentanil—Headache—Doxorubicin—pancreatic cancer	0.0001	0.000907	CcSEcCtD
Alfentanil—Nausea—Doxorubicin—pancreatic cancer	9.5e-05	0.00086	CcSEcCtD
Alfentanil—CYP3A5—pancreas—pancreatic cancer	7.33e-05	0.037	CbGeAlD
Alfentanil—CYP3A5—digestive system—pancreatic cancer	6.26e-05	0.0316	CbGeAlD
Alfentanil—ABCB1—islet of Langerhans—pancreatic cancer	5.54e-05	0.0279	CbGeAlD
Alfentanil—CYP3A4—digestive system—pancreatic cancer	4.7e-05	0.0237	CbGeAlD
Alfentanil—ABCB1—pancreas—pancreatic cancer	3.89e-05	0.0196	CbGeAlD
Alfentanil—ABCB1—digestive system—pancreatic cancer	3.32e-05	0.0168	CbGeAlD
